A Tale from the Dusty Corner: ProQR Therapeutics N.V (PRQR) Stock
Chardan Capital Markets raised the price target for the ProQR Therapeutics N.V (NASDAQ:PRQR) stock from “a Neutral” to “a Buy”. The rating was released on November 08, 2023, according to finviz. We previously noted in another research note published on March 30, 2023 by JMP Securities that upgraded the stock from a Mkt perform to […]
ProQR Therapeutics N.V (PRQR) Stock is poised for a successful quarter
Chardan Capital Markets raised the price target for the ProQR Therapeutics N.V (NASDAQ:PRQR) stock from “a Neutral” to “a Buy”. The rating was released on November 08, 2023, according to finviz. We previously noted in another research note published on March 30, 2023 by JMP Securities that upgraded the stock from a Mkt perform to […]
